Abiopharma

Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Safety Shot Appoints Markita Russell as Chief Financial Officer

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

Envista Reports Second Quarter 2025 Results

ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance

New Form 10-Q - INTEGRA LIFESCIENCES HOLDINGS CORP Filed: 2025-07-31 AccNo: 0000917520-25-000074 Size: 11 MB

New Form 10-Q - Spok Holdings, Inc Filed: 2025-07-31 AccNo: 0001289945-25-000044 Size: 5 MB

Orchestra BioMed Announces Proposed Public Offering

New Form 8-K - Xencor Inc Filed: 2025-07-31 AccNo: 0001326732-25-000063 Size: 179 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

MindMed Reports Q2 2025 Financial Results and Business Updates

CareDx - CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress